View in EDS HTML Full Text PDF Full Text

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome.

Saved in:
Bibliographic Details
Title: Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome.
Authors: Frățilă, Georgiana1 (AUTHOR) valentina-georgiana.fratila@drd.umfcd.ro, Sorohan, Bogdan Marian2,3 (AUTHOR) bogdan.sorohan@yahoo.com, Achim, Camelia1,2 (AUTHOR) camelia.achim@umfcd.ro, Andronesi, Andreea1,2 (AUTHOR) andreea.andronesi@umfcd.ro, Obrișcă, Bogdan1,2 (AUTHOR) bogdan.obrisca@drd.umfcd.ro, Lupușoru, Gabriela1,2 (AUTHOR) gabriela.lupusoru@umfcd.ro, Zilișteanu, Diana1,2 (AUTHOR) diana.zilisteanu@umfcd.ro, Jurubiță, Roxana1 (AUTHOR) roxana_jurubita@yahoo.com, Bobeică, Raluca1 (AUTHOR) ralbobeica@gmail.com, Bălănică, Sonia1 (AUTHOR) sonia.balanica@gmail.com, Micu, Georgia1 (AUTHOR) elenageorgia.micu@gmail.com, Mocanu, Valentin1 (AUTHOR) valentin-dumitrel.mocanu@drd.umfcd.ro, Ismail, Gener1,2 (AUTHOR) gener.ismail@umfcd.ro
Source: Journal of Clinical Medicine. Nov2023, Vol. 12 Issue 21, p6895. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm12216895